Page last updated: 2024-11-04

vorinostat and Pregnancy

vorinostat has been researched along with Pregnancy in 12 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Research Excerpts

ExcerptRelevanceReference
"Depression is a disabling psychiatric disorder affecting millions of people all around the world."1.62SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class. ( Amini-Khoei, H; Dehpour, AR; Ershadi, ASB; Hosseini, MJ, 2021)
"Sevoflurane is a widely used volatile anesthetic in clinical practice."1.51Suberoylanilide hydroxamic acid (SAHA) alleviates the learning and memory impairment in rat offspring caused by maternal sevoflurane exposure during late gestation. ( Feng, N; Hu, Y; Li, M; Liu, Y; Liu, Z; Luo, F; Wu, L; Xu, L; Yu, Q; Zhao, W, 2019)
"SAHA and TSA could inhibit total HDAC activity and placental HDAC1/2/3 expression both in Bewo and JAR, but displayed a transient induction of HDAC mRNA or protein level after being treated at low dosage or prolonged exposure to drugs."1.46The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines. ( Duan, H; Hua, Y; Li, Q; Li, Y; Qiu, D; Wang, C; Wang, T; Zhang, Y; Zhou, K, 2017)
" Our previous studies have demonstrated the social cognition deficits observed in this model, a major core symptom of ASD, to be ameliorated following chronic administration of histone deacetylase (HDAC) inhibitors."1.40Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders. ( Cassidy, AW; Foley, AG; Regan, CM, 2014)
"Animals were dosed on Gestation Days 6-20 or 7-20, respectively, with litter/fetal parameters evaluated on GD 21 and 28, respectively."1.34Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits. ( Kerr, JS; Turner, KJ; Wise, LD, 2007)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's8 (66.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Song, XY1
Liu, XW1
Wang, J1
Ershadi, ASB1
Amini-Khoei, H1
Hosseini, MJ1
Dehpour, AR1
Jin, L1
Guo, Q1
Zhu, HY1
Xing, XX1
Zhang, GL1
Xuan, MF1
Luo, QR1
Luo, ZB1
Wang, JX1
Choe, HM1
Paek, HJ1
Yin, XJ1
Kang, JD1
Lin, J1
Wang, S1
Feng, Y1
Zhao, W4
Luo, F2
Feng, N2
Melchior, M1
Juif, PE1
Gazzo, G1
Petit-Demoulière, N1
Chavant, V1
Lacaud, A1
Goumon, Y1
Charlet, A1
Lelièvre, V1
Poisbeau, P1
Yu, Q1
Hu, Y1
Liu, Z1
Li, M1
Xu, L1
Wu, L1
Liu, Y1
Foley, AG1
Cassidy, AW1
Regan, CM1
Kim, MJ1
Oh, HJ1
Kim, GA1
Suh, HN1
Jo, YK1
Choi, YB1
Kim, DH1
Han, HJ1
Lee, BC1
Duan, H1
Wang, C1
Zhou, K1
Wang, T1
Li, Y1
Qiu, D1
Li, Q1
Zhang, Y1
Hua, Y1
Chen, SH1
Wu, HM1
Ossola, B1
Schendzielorz, N1
Wilson, BC1
Chu, CH1
Chen, SL1
Wang, Q1
Zhang, D1
Qian, L1
Li, X1
Hong, JS1
Lu, RB1
Wise, LD1
Turner, KJ1
Kerr, JS1
Giavini, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A 12-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Related Mechanism of Sulforaphane in Treatment of Autism Spectrum Disorder[NCT02879110]110 participants (Actual)Interventional2016-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

12 other studies available for vorinostat and Pregnancy

ArticleYear
Suberoylanilide hydroxamic acid (SAHA) attenuates memory impairment in the offspring of rats exposed to sevoflurane anesthesia.
    Biochemical and biophysical research communications, 2023, 02-05, Volume: 643

    Topics: Anesthesia; Animals; Female; Hippocampus; Learning; Memory Disorders; MicroRNAs; Pregnancy; Rats; Se

2023
SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class.
    Neurochemical research, 2021, Volume: 46, Issue:5

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Cognitive Dysfunction; Depression; Female; Fluoxet

2021
Histone deacetylase inhibitor M344 significantly improves nuclear reprogramming, blastocyst quality, and in vitro developmental capacity of cloned pig embryos.
    Journal of animal science, 2017, Volume: 95, Issue:3

    Topics: Acetylation; Animals; Blastocyst; Cellular Reprogramming; Embryo, Mammalian; Embryonic Development;

2017
Propofol exposure during early gestation impairs learning and memory in rat offspring by inhibiting the acetylation of histone.
    Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:5

    Topics: Acetylation; Anesthesia; Animals; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Drug

2018
Pharmacological rescue of nociceptive hypersensitivity and oxytocin analgesia impairment in a rat model of neonatal maternal separation.
    Pain, 2018, Volume: 159, Issue:12

    Topics: Action Potentials; Analgesics; Animals; Animals, Newborn; Antidiuretic Hormone Receptor Antagonists;

2018
Suberoylanilide hydroxamic acid (SAHA) alleviates the learning and memory impairment in rat offspring caused by maternal sevoflurane exposure during late gestation.
    The Journal of toxicological sciences, 2019, Volume: 44, Issue:3

    Topics: Anesthetics, Inhalation; Animals; Cyclic AMP Response Element-Binding Protein; Female; Hippocampus;

2019
Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
    European journal of pharmacology, 2014, Mar-15, Volume: 727

    Topics: Acetylation; Animals; Behavior, Animal; Cerebellar Cortex; Child Development Disorders, Pervasive; C

2014
Altering histone acetylation status in donor cells with suberoylanilide hydroxamic acid does not affect dog cloning efficiency.
    Theriogenology, 2015, Oct-15, Volume: 84, Issue:7

    Topics: Acetylation; Animals; Apoptosis; Cellular Reprogramming; Cloning, Organism; Dogs; Dose-Response Rela

2015
The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines.
    Placenta, 2017, Volume: 49

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Female; Histone Deacetylase Inhi

2017
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage.
    British journal of pharmacology, 2012, Volume: 165, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Astrocytes; Cell Survival; Cells, Cultured;

2012
Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2007, Volume: 80, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Dose-Response Relationship, Drug; Enzyme Inhibito

2007
Comment on developmental toxicity evaluation on Vorinostat and relationship with HDAC inhibition.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2007, Volume: 80, Issue:5

    Topics: Abnormalities, Drug-Induced; Animals; Bone Development; Enzyme Inhibitors; Female; Fetal Development

2007